Omega-3 Docosahexaenoic Acid Is a Mediator of Fate-Decision of Adult Neural Stem Cells
- PMID:31480215
- PMCID: PMC6747551
- DOI: 10.3390/ijms20174240
Omega-3 Docosahexaenoic Acid Is a Mediator of Fate-Decision of Adult Neural Stem Cells
Abstract
The mammalian brain is enriched with lipids that serve as energy catalyzers or secondary messengers of essential signaling pathways. Docosahexaenoic acid (DHA) is an omega-3 fatty acid synthesized de novo at low levels in humans, an endogenous supply from its precursors, and is mainly incorporated from nutrition, an exogeneous supply. Decreased levels of DHA have been reported in the brains of patients with neurodegenerative diseases. Preventing this decrease or supplementing the brain with DHA has been considered as a therapy for the DHA brain deficiency that could be linked with neuronal death or neurodegeneration. The mammalian brain has, however, a mechanism of compensation for loss of neurons in the brain: neurogenesis, the birth of neurons from neural stem cells. In adulthood, neurogenesis is still present, although at a slower rate and with low efficiency, where most of the newly born neurons die. Neural stem/progenitor cells (NSPCs) have been shown to require lipids for proper metabolism for proliferation maintenance and neurogenesis induction. Recent studies have focused on the effects of these essential lipids on the neurobiology of NSPCs. This review aimed to introduce the possible use of DHA to impact NSPC fate-decision as a therapy for neurodegenerative diseases.
Keywords: adult neurogenesis; docosahexaenoic acid; neural stem cell; neuroprotection; omega-3 fatty acids.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
- Targeting the Brain with a Neuroprotective Omega-3 Fatty Acid to Enhance Neurogenesis in Hypoxic Condition in Culture.Lo Van A, Sakayori N, Hachem M, Belkouch M, Picq M, Fourmaux B, Lagarde M, Osumi N, Bernoud-Hubac N.Lo Van A, et al.Mol Neurobiol. 2019 Feb;56(2):986-999. doi: 10.1007/s12035-018-1139-0. Epub 2018 Jun 1.Mol Neurobiol. 2019.PMID:29858775
- Distinctive effects of arachidonic acid and docosahexaenoic acid on neural stem /progenitor cells.Sakayori N, Maekawa M, Numayama-Tsuruta K, Katura T, Moriya T, Osumi N.Sakayori N, et al.Genes Cells. 2011 Jul;16(7):778-90. doi: 10.1111/j.1365-2443.2011.01527.x. Epub 2011 Jun 13.Genes Cells. 2011.PMID:21668588
- Docosahexaenoic acid (DHA) enhances the therapeutic potential of neonatal neural stem cell transplantation post-Traumatic brain injury.Ghazale H, Ramadan N, Mantash S, Zibara K, El-Sitt S, Darwish H, Chamaa F, Boustany RM, Mondello S, Abou-Kheir W, Soueid J, Kobeissy F.Ghazale H, et al.Behav Brain Res. 2018 Mar 15;340:1-13. doi: 10.1016/j.bbr.2017.11.007. Epub 2017 Nov 7.Behav Brain Res. 2018.PMID:29126932
- Effects of addictive drugs on adult neural stem/progenitor cells.Xu C, Loh HH, Law PY.Xu C, et al.Cell Mol Life Sci. 2016 Jan;73(2):327-48. doi: 10.1007/s00018-015-2067-z. Epub 2015 Oct 14.Cell Mol Life Sci. 2016.PMID:26468052Free PMC article.Review.
- Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients throughout the Life Cycle.Sambra V, Echeverria F, Valenzuela A, Chouinard-Watkins R, Valenzuela R.Sambra V, et al.Nutrients. 2021 Mar 18;13(3):986. doi: 10.3390/nu13030986.Nutrients. 2021.PMID:33803760Free PMC article.Review.
Cited by
- Investigation of Lysophospholipids-DHA transport across anin vitro human model of blood brain barrier.Hachem M, Ali AH, Yildiz I, Landry C, Gosselet F.Hachem M, et al.Heliyon. 2024 Oct 2;10(19):e38871. doi: 10.1016/j.heliyon.2024.e38871. eCollection 2024 Oct 15.Heliyon. 2024.PMID:39421371Free PMC article.
- Emerging Role of Phospholipids and Lysophospholipids for Improving Brain Docosahexaenoic Acid as Potential Preventive and Therapeutic Strategies for Neurological Diseases.Hachem M, Nacir H.Hachem M, et al.Int J Mol Sci. 2022 Apr 2;23(7):3969. doi: 10.3390/ijms23073969.Int J Mol Sci. 2022.PMID:35409331Free PMC article.Review.
- Dolphin CONTINUE: a multi-center randomized controlled trial to assess the effect of a nutritional intervention on brain development and long-term outcome in infants born before 30 weeks of gestation.Janson E, Koolschijn PCMP, Schipper L, Boerma TD, Wijnen FNK, de Boode WP, van den Akker CHP, Licht-van der Stap RG, Nuytemans DHGM, Onland W, Obermann-Borst SA, Dudink J, de Theije CGM, Benders MJNL, van der Aa NE.Janson E, et al.BMC Pediatr. 2024 Jun 7;24(1):384. doi: 10.1186/s12887-024-04849-1.BMC Pediatr. 2024.PMID:38849784Free PMC article.Clinical Trial.
- Lipid Mediated Regulation of Adult Stem Cell Behavior.Clémot M, Sênos Demarco R, Jones DL.Clémot M, et al.Front Cell Dev Biol. 2020 Feb 28;8:115. doi: 10.3389/fcell.2020.00115. eCollection 2020.Front Cell Dev Biol. 2020.PMID:32185173Free PMC article.Review.
- Susceptibility of Female Mice to the Dietary Omega-3/Omega-6 Fatty-Acid Ratio: Effects on Adult Hippocampal Neurogenesis and Glia.Rodríguez-Iglesias N, Nadjar A, Sierra A, Valero J.Rodríguez-Iglesias N, et al.Int J Mol Sci. 2022 Mar 21;23(6):3399. doi: 10.3390/ijms23063399.Int J Mol Sci. 2022.PMID:35328825Free PMC article.
References
- Moreno-Jiménez E.P., Flor-García M., Terreros-Roncal J., Rábano A., Cafini F., Pallas-Bazarra N., Ávila J., Llorens-Martín M. Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease. Nat. Med. 2019;25:554–560. doi: 10.1038/s41591-019-0375-9. - DOI - PubMed
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources